Description

This issue of Vital Signs, released on July 10, 2006, provides a strategic overview of the increased use of direct to consumer marketing within the medical device industry and compares / contrasts it to the same practice within the pharmaceutical industry. Additionally, an emerging company profile is provided on Small Bone Innovations, a company specializing in the development and manufacturing of products that specifically focus on small bones and joints. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of June 26 - June 30, 2006.